Live Breaking News & Updates on Monument Therapeutics
Stay updated with breaking news from Monument therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that Monument Therapeutics Limited (“Monument”) a p. ....
During the conference, we caught up with some of the speakers to learn more about their work, what they were presenting, and their thoughts about the future of Oncology and Precision Medicine. ....
Operations can have cognitive side-effects, particularly in the over-65s but also in the very young, where anaesthetic has been linked to ADHD. How can science minimise the danger? ....